SOCIETE GENERALE has begun marketing the IPO of French teleconferencing company Genesys, which is likely to be the last international offering from the country this year. The deal could raise up to Ffr200m with most of the proceeds accruing to the company. Some 1.186m ordinary shares are being offered to investors and Genesys plans to list its stock on the Nouveau Marché after the offering. In addition to the capital increase, shares are being sold by BNP, whose stake will fall from 35.5% to 16%. CDC will sell down from 26.7% to 12.3%, the stake of Worms & Cie will fall from 12.5% to 4.8%, GBG will cut its stake from 4.7% to 3.5% and the holding of Vertex will fall from 14.1% to 10.3%.
December 05, 1997